Short Interest in Myomo, Inc. (NYSEAMERICAN:MYO) Declines By 39.1%

Myomo, Inc. (NYSEAMERICAN:MYO) was the recipient of a large drop in short interest in August. As of August 14th, there was short interest totaling 1,124,493 shares, a drop of 39.1% from the July 30th total of 1,847,205 shares. Approximately 3.2% of the shares of the stock are sold short. Based on an average daily volume of 889,567 shares, the days-to-cover ratio is presently 1.3 days.

Insider Buying and Selling at Myomo

In other news, insider Harry Kovelman sold 17,250 shares of the stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $1.73, for a total value of $29,842.50. Following the completion of the transaction, the insider owned 105,983 shares of the company’s stock, valued at approximately $183,350.59. This represents a 14.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas F. Kirk purchased 40,002 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were bought at an average cost of $1.27 per share, for a total transaction of $50,802.54. Following the completion of the acquisition, the director directly owned 693,865 shares in the company, valued at $881,208.55. The trade was a 6.12% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 12.14% of the company’s stock.

Institutional Investors Weigh In On Myomo

Large investors have recently added to or reduced their stakes in the business. Engineers Gate Manager LP grew its position in shares of Myomo by 62.8% during the 2nd quarter. Engineers Gate Manager LP now owns 30,097 shares of the company’s stock worth $65,000 after buying an additional 11,614 shares during the period. Bank of America Corp DE grew its holdings in shares of Myomo by 93.6% during the third quarter. Bank of America Corp DE now owns 30,412 shares of the company’s stock valued at $27,000 after buying an additional 14,705 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Myomo during the 1st quarter worth approximately $75,000. Invesco Ltd. purchased a new position in shares of Myomo during the second quarter valued at approximately $37,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Myomo during the second quarter worth $38,000. Institutional investors and hedge funds own 44.99% of the company’s stock.

Myomo News Summary

Here are the key news stories impacting Myomo this week:

• Positive Sentiment: Ascendiant raised its FY2026 EPS forecast to ($0.32) from ($0.34) and its FY2027 forecast to ($0.22) from ($0.25), indicating expectations for improved profitability. The firm also increased estimates for Q3 2026 to ($0.08) from ($0.09), Q1 2027 to ($0.07) from ($0.08), Q2 2027 to ($0.06) from ($0.08), and Q3 2027 to ($0.05) from ($0.07). Myomo analyst estimates
• Neutral Sentiment: The $10.00 target is substantially above Myomo’s recent trading level, signaling significant potential upside if the company can execute on growth and narrow losses. However, Ascendiant still expects full-year losses through FY2027, while the current consensus estimate is a ($0.33) loss for the current year.
• Negative Sentiment: Ascendiant lowered its Q4 2026 EPS estimate to ($0.08) from ($0.06) and its Q4 2027 estimate to ($0.04) from ($0.03), suggesting somewhat weaker near-term and late-period earnings than previously expected. The continued projected losses may limit investor enthusiasm despite the improved annual forecasts.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets upped their price target on shares of Myomo from $9.50 to $10.00 and gave the stock a “buy” rating in a report on Monday, June 8th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $10.00.

Myomo Trading Down 4.0%

Shares of Myomo stock traded down $0.06 during trading on Tuesday, hitting $1.43. The company’s stock had a trading volume of 236,099 shares, compared to its average volume of 604,885. The company has a debt-to-equity ratio of 1.98, a current ratio of 2.31 and a quick ratio of 2.01. Myomo has a 52 week low of $0.60 and a 52 week high of $1.89. The stock has a market cap of $56.64 million, a price-to-earnings ratio of -4.21 and a beta of 1.50. The stock has a 50-day moving average price of $1.24 and a two-hundred day moving average price of $1.01.

Myomo (NYSEAMERICAN:MYO) last announced its earnings results on Wednesday, August 5th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.01. The business had revenue of $11.70 million during the quarter, compared to analyst estimates of $10.35 million. Myomo had a negative return on equity of 138.85% and a negative net margin of 33.53%. Equities research analysts anticipate that Myomo will post -0.33 EPS for the current fiscal year.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.